Emerson Electric Co.
EMR Industrials · Specialty Industrial MachineryNot yet scored
Filing.fyi has not computed forensic scores for EMR yet. Scores appear after the company's next data refresh.
What the filing actually says.
The filing supports a narrower reading than the headline earnings growth suggests. Management's own adjusted EPS bridge shows operations adding $0.08 and foreign currency adding $0.07, while software renewal timing subtracted $0.09. The 27 percent rise in earnings attributable to common stockholders, to $618 million, is largely a comparison effect. The prior-year quarter carried $168 million of acquisition and divestiture fees and related costs, mainly tied to AspenTech, and the filing describes a $143 million decrease in those fees as a major driver of lower other deductions. Segment results show the mix shifting. Test & Measurement grew underlying sales 12 percent, offsetting weakness in Control Systems & Software, where sales were $1,089 million and underlying sales fell 2 percent. Intelligent Devices adjusted EBITA margin rose to 27.9 percent, yet Final Control restructuring costs rose to $25 million from $3 million, a change readers may want to look at more closely. Geographically, underlying sales were up 9 percent in the U.S. but down 5 percent internationally, with China down 9 percent. Management attributes about 1 percentage point of underlying sales to the Middle East conflict and warns that continuation or escalation could adversely affect future periods. Readers may also want to follow the IEEPA refund disclosures, since the CBP claims portal launched April 20, 2026 could eventually produce a benefit the company has not recorded. Against the longer series, fiscal 2025 revenue of $18.02 billion sits well below the $19.63 billion reported for fiscal 2022. Overall, the filing shows steady reported growth with thinner underlying momentum and a higher interest burden.
Catalyst.For the quarter ended March 31, 2026, net sales rose 3 percent to $4,562 million from $4,432 million, but foreign currency translation added 2.5 percent, so underlying sales rose only 0.5 percent. That underlying figure reflected 3.5 percent higher price offset by 3 percent lower volume. Test & Measurement was the clear driver, with sales of $414 million, up 16 percent reported and 12 percent underlying on strength in aerospace and defense and semiconductors. Diluted EPS rose to $1.10 from $0.86, though the prior-year quarter carried AspenTech acquisition costs, and adjusted diluted EPS grew 4 percent to $1.54. For fiscal 2025, revenues were $18.02 billion, up from $17.49 billion in fiscal 2024.
Hidden risk.Reported earnings growth flatters the operating picture. Interest expense, net more than doubled to $84 million from $41 million in the quarter. The effective tax rate fell to 22 percent from 32 percent, largely because the prior year included AspenTech-related discrete tax items, so the comparison base is distorted. Software and Systems adjusted EBITA margin fell 2.5 points to 29.2 percent, with management attributing about 3 points to software renewal timing. Tariffs reduced gross margin by roughly 0.8 points, and the company recorded no benefit for possible IEEPA tariff refunds because their amount and timing remain uncertain.
What traders are betting.
The metric
Shares that traders have borrowed and sold, betting the price will fall, and not yet bought back. Brokers report the total to FINRA twice a month. Days to cover divides it by the shares that change hands on a typical day.
- Shares sold short
- 8.8M
- Change since Aug 31
- +0.3%
- Days to cover
- 3.7
What it tells us
Few traders are betting against EMR. Levels this low are common for large, widely held companies.
Little changed since the Aug 31 report (+0.3%).
At normal trading volume, short sellers would need about 3.7 days to buy back every borrowed share.
How investors use it
- Squeeze watching. Some aggressive traders seek out heavily shorted stocks, betting that good news will force short sellers to buy back shares and push the price higher.
- Hedging. Funds short one company to offset risk in another, often owning a stronger business and shorting a weaker one in the same industry.
- Timing. Chart-based traders pair rising short interest with price patterns, such as a break below a level where buyers used to step in, to decide when to enter or exit.
- Warning sign. Some owners treat a sharp rise in short interest as a red flag and respond by tightening stop-loss orders or holding smaller positions.
Annual report, quarterly reports & proxy statement
The annual report (10-K), quarterly reports (10-Q), proxy statement (DEF 14A) and current reports (8-K) Emerson Electric filed in the last 12 months, each linked to the original document on SEC EDGAR.
- Oct 13, 20268-KCurrent reportItem 2.02: Results of operations (earnings)0EDGAR →
- Aug 4, 202610-QQuarterly report0EDGAR →
- May 5, 202610-QQuarterly report (2026-03-31)Period: 2026-03-310EDGAR →
- May 5, 20268-KCurrent report (2026-05-05)Item 2.02: Results of operations (earnings); Item 5.02: Departure/appointment of officers or directors; Item 7.01: Regulation FD disclosure (investor materials)0EDGAR →
- Feb 13, 20268-KCurrent report (2026-02-10)Item 1.01: Signed a material agreement0EDGAR →
- Feb 6, 20268-KCurrent report (2026-02-03)No specific items found in 8-K.0EDGAR →
- Dec 12, 2025DEF 14AProxy statement (2025-09-30)0EDGAR →
- Nov 10, 202510-KAnnual report (2025-09-30)Period: 2025-09-300EDGAR →
If this case caught your eye
Financial Shenanigans
Schilit's framework for the seven shenanigan types is the standard reference for the kind of MD&A pattern-matching this site does.
View on Amazon →The Interpretation of Financial Statements
The original — and still the clearest — explanation of why working-capital trends matter more than headline earnings.
View on Amazon →Quality of Earnings
Out of print, expensive, worth it. The chapter on receivables-vs-revenue divergence applies almost word-for-word to most distressed filings.
View on Amazon →